Perceptive Advisors’s Biohaven BHVN Stock Holding History

Perceptive Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500,000	Closed	-$5.64M	–	100
2025 Q4	$5.64M	Buy	+500,000	New	+$6.19M	0.1%	88

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perceptive Advisors's BHVN Position: Q4 2024 in Review

Perceptive Advisors sold out of Biohaven (BHVN) in Q4 2024, closing a stake of 1,485,232 shares — an estimated $74.2M sold.

Perceptive Advisors first reported a position in BHVN in Q2 2023 and held it in 6 quarters. The position peaked at $94.3M in Q1 2024. 256 funds tracked by Wall St. Rank hold BHVN as of Q4 2024.

Perceptive Advisors reported no remaining Biohaven position as of Q4 2024 after selling out during the quarter.
Perceptive Advisors sold 1,485,232 Biohaven shares in Q4 2024, an estimated $74.2M.
Perceptive Advisors first reported a position in Biohaven in Q2 2023 and held it in 6 quarters.
Perceptive Advisors's Biohaven position peaked at $94.3M in Q1 2024.
256 funds tracked by Wall St. Rank held Biohaven as of Q4 2024.

Based on Perceptive Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.